                         SEQUENCE LISTING

<110>  Myrovlytis Technology Ventures Ltd
 
<120>  Compositions/substances for the treatment of renal cell carcinoma

<130>  WOP6964

<150>  GB1107825.0
<151>  2011-05-11

<160>  18    

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RNA with 2 DNA bases at 3' end

<400>  1
ccuccacagu cauagccuat t                                                 21


<210>  2
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RNA with 2 DNA bases at 3' end

<400>  2
uaggcuauga cuguggaggc c                                                 21


<210>  3
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RNA with 2 DNA bases at 3' end

<400>  3
ggcuuauuug cauaucauat t                                                 21


<210>  4
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RNA with 2 DNA bases at 3' end

<400>  4
uaugauaugc aaauaagcca g                                                 21


<210>  5
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RNA with 2 DNA bases at 3' end

<400>  5
gcauggagga ugaugcuaut t                                                 21


<210>  6
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RNA with 2 DNA bases at 3' end

<400>  6
auagcaucau ccuccaugcc g                                                 21


<210>  7
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RNA with 2 DNA bases at 3' end

<400>  7
ggacuugaau ugacuaguut t                                                 21


<210>  8
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RNA with 2 DNA bases at 3' end

<400>  8
aacuagucaa uucaagucct g                                                 21


<210>  9
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RNA with 2 DNA bases at 3' end

<400>  9
guaucauaac auucggguat t                                                 21


<210>  10
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RNA with 2 DNA bases at 3' end

<400>  10
uacccgaaug uuaugauact c                                                 21


<210>  11
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RNA with 2 DNA bases at 3' end

<400>  11
ggagcgacac gcuaauucat t                                                 21


<210>  12
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RNA with 2 DNA bases at 3' end

<400>  12
ugaauuagcg ugucgcucca g                                                 21


<210>  13
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RNA with 2 DNA bases at 3' end

<400>  13
agacugaacu ccgaacagat t                                                 21


<210>  14
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RNA with 2 DNA bases at 3' end

<400>  14
ucuguucgga guucagucuc t                                                 21


<210>  15
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RNA with 2 DNA bases at 3' end

<400>  15
ccacgagucu ucacaugaat t                                                 21


<210>  16
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RNA with 2 DNA bases at 3' end

<400>  16
uucaugugaa gacucguggg a                                                 21


<210>  17
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RNA with 2 DNA bases at 3' end

<400>  17
gcaccucaga gaccagugat t                                                 21


<210>  18
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RNA with 2 DNA bases at 3' end

<400>  18
ucacuggucu cugaggugct c                                                 21


